Search results
Ozempic reduces risk of serious illness and death in people withdiabetes and kidney disease, study...
CNN via Yahoo News· 4 hours agoWeekly injections of semaglutide medications like Ozempic significantly reduce the risk of serious...
Ozempic could protect against kidney disease, heart attacks and diabetes
Daily Telegraph· 3 hours ago“Weight-loss” jabs could protect against kidney disease, as well as heart attacks and diabetes, a...
Ozempic Slows Kidney Disease, Novo Nordisk Study Finds
The Wall Street Journal· 3 hours agoNovo Nordisk’s Ozempic drug slows the progression of chronic kidney disease and cuts the risk of...
Type 2 diabetes: £1m funding for heart treatment research
BBC News· 6 hours agoA £1m grant has been given to a university to support research into type 2 diabetes. The British...
People using popular drugs for weight loss, diabetes are more likely to be diagnosed with stomach...
CNN.com· 4 days agoInjected medications that treat diabetes and obesity increase the risk of a rare but serious side...
Ozempic cuts kidney-disease risks, research finds
Market Watch· 59 minutes agoNovo Nordisk’s diabetes drug Ozempic reduces the risk of kidney failure and death in patients who have both Type 2 diabetes and chronic kidney disease, ...
Skyrocketing diabetes medication costs force life-and-death decisions for patients
WAGA fox local articles via Yahoo News· 11 hours agoATLANTA - The cost of diabetes medications is on the rise. In some cases, prices for insulin and new...
Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial
Reuters· 4 hours ago, opens new tab Ozempic slowed the worsening of kidney dysfunction in patients with type 2 diabetes...
Ozempic Cuts Risk of Chronic Kidney Disease Complications, Study Finds
New York Times· 4 hours agoA major clinical trial showed such promising results that the drug’s maker halted it early. Dani...
Lake Street Capital Increases Tandem Diabetes Care (NASDAQ:TNDM) Price Target to $75.00
ETF DAILY NEWS· 11 hours agoTandem Diabetes Care (NASDAQ:TNDM – Get Free Report) had its price objective upped by Lake Street Capital from $60.00 to $75.00 in a note issued to investors on Wednesday, ...